PlainRecalls
FDA Devices Critical Class I Terminated

E25Bio COVID-19 Direct Antigen Rapid Test ; E25Bio COVID-19 DART Kit

Reported: February 16, 2022 Initiated: January 27, 2022 #Z-0564-2022

Product Description

E25Bio COVID-19 Direct Antigen Rapid Test ; E25Bio COVID-19 DART Kit

Reason for Recall

The Test is not authorized, cleared, or approved by FDA for clinical diagnostic or screening purposes. It was distributed without sufficient directions or controls in place.

Details

Recalling Firm
E25Bio, Inc.
Units Affected
73,300 units
Distribution
US Nationwide distribution in the states of MA, FL, and HI.
Location
Cambridge, MA

Frequently Asked Questions

What product was recalled?
E25Bio COVID-19 Direct Antigen Rapid Test ; E25Bio COVID-19 DART Kit. Recalled by E25Bio, Inc.. Units affected: 73,300 units.
Why was this product recalled?
The Test is not authorized, cleared, or approved by FDA for clinical diagnostic or screening purposes. It was distributed without sufficient directions or controls in place.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 16, 2022. Severity: Critical. Recall number: Z-0564-2022.